Short interest in SAB Biotherapeutics Inc (NASDAQ:SABS) decreased during the last reporting period, falling from 79.82K to 58.76K. This put 0.84% of the company's publicly available shares short.

Short interest for SAB Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of SAB Biotherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 169.11K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.